These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 8950780

  • 1. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
    Geng JP, Cheng CH, Castellino FJ.
    Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
    [Abstract] [Full Text] [Related]

  • 2. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
    Geng JP, Castellino FJ.
    Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles.
    Jalbert LR, Chan JC, Christiansen WT, Castellino FJ.
    Biochemistry; 1996 Jun 04; 35(22):7093-9. PubMed ID: 8679535
    [Abstract] [Full Text] [Related]

  • 5. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J, Ido M, Hayashi T, Suzuki K.
    Thromb Haemost; 1996 Feb 04; 75(2):275-82. PubMed ID: 8815576
    [Abstract] [Full Text] [Related]

  • 6. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
    Dahlbäck B.
    Thromb Haemost; 1991 Jul 12; 66(1):49-61. PubMed ID: 1833851
    [Abstract] [Full Text] [Related]

  • 7. Solution structure of the N-terminal EGF-like domain from human factor VII.
    Muranyi A, Finn BE, Gippert GP, Forsén S, Stenflo J, Drakenberg T.
    Biochemistry; 1998 Jul 28; 37(30):10605-15. PubMed ID: 9692950
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity.
    Zhang L, Jhingan A, Castellino FJ.
    Blood; 1992 Aug 15; 80(4):942-52. PubMed ID: 1498334
    [Abstract] [Full Text] [Related]

  • 10. Functions of individual gamma-carboxyglutamic acid (Gla) residues of human protein c. Determination of functionally nonessential Gla residues and correlations with their mode of binding to calcium.
    Christiansen WT, Tulinsky A, Castellino FJ.
    Biochemistry; 1994 Dec 20; 33(50):14993-5000. PubMed ID: 7999756
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Properties of recombinant chimeric human protein C and activated protein C containing the gamma-carboxyglutamic acid and trailing helical stack domains of protein C replaced by those of human coagulation factor IX.
    Christiansen WT, Castellino FJ.
    Biochemistry; 1994 May 17; 33(19):5901-11. PubMed ID: 8180219
    [Abstract] [Full Text] [Related]

  • 13. EGF-like module pair 3-4 in vitamin K-dependent protein S: modulation of calcium affinity of module 4 by module 3, and interaction with factor X.
    Stenberg Y, Muranyi A, Steen C, Thulin E, Drakenberg T, Stenflo J.
    J Mol Biol; 1999 Oct 29; 293(3):653-65. PubMed ID: 10543957
    [Abstract] [Full Text] [Related]

  • 14. Topological studies of the amino terminal modules of vitamin K-dependent protein S using monoclonal antibody epitope mapping and molecular modeling.
    Giri TK, Villoutreix BO, Wallqvist A, Dahlbäck B, de Frutos PG.
    Thromb Haemost; 1998 Nov 29; 80(5):798-804. PubMed ID: 9843174
    [Abstract] [Full Text] [Related]

  • 15. Mouse recombinant protein C variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma.
    Krisinger MJ, Guo LJ, Salvagno GL, Guidi GC, Lippi G, Dahlbäck B.
    FEBS J; 2009 Nov 29; 276(22):6586-602. PubMed ID: 19817854
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a thrombomodulin binding site on protein C and its comparison to an activated protein C binding site for factor Va.
    Gale AJ, Griffin JH.
    Proteins; 2004 Feb 15; 54(3):433-41. PubMed ID: 14747992
    [Abstract] [Full Text] [Related]

  • 17. Construction, expression, and properties of a recombinant chimeric human protein C with replacement of its growth factor-like domains by those of human coagulation factor IX.
    Yu S, Zhang L, Jhingan A, Christiansen WT, Castellino FJ.
    Biochemistry; 1994 Jan 25; 33(3):823-31. PubMed ID: 8292611
    [Abstract] [Full Text] [Related]

  • 18. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J, Perera L, Stafford D, Pedersen L.
    J Mol Biol; 2001 Apr 13; 307(5):1503-17. PubMed ID: 11292356
    [Abstract] [Full Text] [Related]

  • 19. Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three-dimensional structures near Arg at position 79 in the first EGF-like domain.
    Takamiya O.
    Thromb Haemost; 1998 Jan 13; 79(1):104-9. PubMed ID: 9459333
    [Abstract] [Full Text] [Related]

  • 20. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties.
    Chang Y, Zajicek J, Castellino FJ.
    Biochemistry; 1997 Jun 24; 36(25):7652-63. PubMed ID: 9201906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.